# OnCo record sgr-2921 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sgr-2921/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sgr-2921" ;
  schema:name "SGR-2921"@en ;
  schema:description "SGR-2921 is a small molecule from Schrödinger that reached phase 1 for relapsed or refractory acute myeloid leukaemia and myelodysplastic syndrome; development has stopped."@en ;
  schema:url <https://onco.cc/drugs/sgr-2921/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1490978/000149097826000068/sdgr-20260630.htm>, <https://www.sec.gov/Archives/edgar/data/1490978/000149097825000099/sdgr-20250630xexx991.htm>, <https://clinicaltrials.gov/search?intr=SGR-2921> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest", "discontinued" ;
  onco:modality "Small molecule (oral)" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:targets <https://onco.cc/targets/cdc7/> ;
  onco:companies <https://onco.cc/companies/schrodinger/> ;
  onco:trials <https://onco.cc/trials/nct05961839/> .